Articles published by BioNTech SE
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
April 22, 2024
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
March 20, 2024
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
March 20, 2024
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
BioNTech Announces Planned Retirement of Sean Marett
March 07, 2024
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
February 08, 2024
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
January 09, 2024
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
BioNTech to Inaugurate First African Site on December 18, 2023
December 12, 2023
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
October 16, 2023
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs
October 16, 2023
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
September 28, 2023
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
September 18, 2023
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
August 30, 2023
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
BioNTech Completes Acquisition of InstaDeep
July 31, 2023
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
BioNTech to Report Second Quarter 2023 Financial Results and Operational Update on August 7, 2023
July 24, 2023
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC
June 29, 2023
From BioNTech SE
Via GlobeNewswire
Tickers
BNTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.